Turnstone Biologics is a clinical-stage biotechnology company focused on developing innovative cancer immunotherapies. Their primary approach involves engineering and advancing tumor-infiltrating lymphocyte (TIL) therapies designed to identify, target, and eradicate solid tumors. The company aims to overcome the limitations of current cancer treatments by providing potent and durable responses for patients with various types of cancer.
Serves as the main hub for corporate leadership, strategic planning, business development, investor relations, and administrative functions.
Situated in a modern office building in the Hudson Square neighborhood of Manhattan, providing a professional environment conducive to its corporate functions. Specific internal architectural details are not publicly emphasized.
The New York headquarters likely fosters a dynamic, results-oriented work culture focused on strategic decision-making, investor relations, and corporate governance, complementing the R&D-focused culture at its other sites.
The New York City location provides Turnstone Biologics with direct access to global financial markets, a rich pool of business talent, and proximity to key stakeholders in the investment community.
Turnstone Biologics supports its clinical development programs globally, primarily by conducting clinical trials in multiple countries to evaluate its TIL therapies. While its physical research and corporate offices are concentrated in North America (USA and Canada), its operational reach for clinical studies, patient recruitment, and potential scientific collaborations extends to key international regions relevant for oncology drug development.
99 Hudson Street, 5th Floor
New York
NY
USA
Address: 10835 Road to the Cure, Suite 150, San Diego, CA 92121
Leverages the rich biotech ecosystem in the San Diego area, providing access to specialized scientific talent, research institutions, and collaborators crucial for advancing their therapeutic pipeline.
Address: 500 Palladium Drive, Suite 2300, Ottawa, ON K2V 1C2, Canada
Accesses Canadian research talent and the local biotechnology innovation ecosystem. May stem from foundational technology or historical collaborations in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Turnstone Biologics' leadership includes:
Turnstone Biologics has been backed by several prominent investors over the years, including:
In the past 12 months (May 2023 - May 2024), Turnstone Biologics strengthened its executive team with the appointment of a new Chief People and Culture Officer in late 2023. No major executive departures have been publicly announced during this period.
Discover the tools Turnstone Biologics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Turnstone Biologics commonly uses the email format combining the first initial of an employee's name followed by their last name, at the company's domain. For example, an employee named Jane Doe would likely have an email address like jdoe@turnstonebio.com.
flast@turnstonebio.com
Format
sfarah@turnstonebio.com
Example
85%
Success rate
GlobeNewswire • March 28, 2024
Turnstone Biologics announced its financial results for the fourth quarter and full year ended December 31, 2023. The company also provided a corporate update, highlighting progress in its lead TIL therapy programs and upcoming milestones....more
GlobeNewswire • December 1, 2023
Turnstone Biologics announced the appointment of Karin Baqi, M.B.A., as Chief People and Culture Officer. Ms. Baqi brings extensive experience in building and scaling human resources functions within the biopharmaceutical industry....more
GlobeNewswire • October 24, 2023
The company announced that the first patient had been dosed in its Phase 1 clinical trial, TIDAL-01, evaluating its lead selected tumor-infiltrating lymphocyte (TIL) therapy candidate in patients with melanoma, colorectal, and breast cancers....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Turnstone Biologics, are just a search away.